Mechanical Engineering Design Process For Combination Products

If you've ever wondered why combination drug-delivery devices take so long to get right, the mechanical engineering phase is a big part of the answer. It's not just about making something that works in a lab — it's about building something that will perform consistently across global manufacturing volumes, under real-world conditions, for real patients.

The process starts with requirements engineering: converting qualitative user needs into measurable mechanical specifications like torque, force profiles, and dimensional tolerances. From there, Design Failure Mode and Effects Analysis (DFMEA) maps out where things can go wrong at the component level, before they do.

Material selection is more demanding than most people expect. Any material in direct or indirect contact with the drug or patient must meet ISO 10993 biocompatibility standards and survive specific sterilization methods — autoclave, gamma, or ethylene oxide. Get that wrong and you're not just looking at a redesign, you're looking at a regulatory problem.

Precision 3D CAD modeling and Finite Element Analysis (FEA) then stress-test the design virtually, catching failure points before physical prototypes are built. This is where rigorous upfront engineering pays off in time and cost downstream.

Access the full article to understand how each engineering phase connects to manufacturing readiness.